Cadrenal Therapeutics, Inc. — Form D

Cadrenal Therapeutics, Inc. of PONTE VEDRA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-18. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
John MurphyDirectorBeaver Falls, PA
Glynn WilsonDirectorPonte Vedra, FL
STEVEN ZELENKOFSKEDirectorPonte Vedra, FL
Douglas LosordoExecutive OfficerPONTE VEDRA, FL
JOHN R MURPHYDirectorPONTE VEDRA, FL
LEE S GOLDENDirectorPONTE VEDRA, FL
JEFFREY K COLEExecutive OfficerPONTE VEDRA, FL
QUANG X PHAMDirectorPONTE VEDRA, FL
QUANG X PHAMExecutive OfficerPONTE VEDRA, FL
JAMES J FERGUSONExecutive OfficerPONTE VEDRA, FL
GLYNN J WILSONDirectorPONTE VEDRA, FL
STEVEN J ZELENKOFSKEDirectorPONTE VEDRA, FL
Jeffrey ColeRelated PersonToronto, A6
Steven W ZelenkofskeDirectorPonte Vedra, FL
Jeff W ColeExecutive OfficerPonte Vedra, FL
Glynn W WilsonDirectorPonte Vedra, FL
Matthew SzotExecutive OfficerPonte Vedra, FL
Matthew SzotRelated PersonPonte Vedra, FL
Douglas W LosordoExecutive OfficerPonte Vedra, FL
Quang PhamDirectorPonte Vedra, FL
Quang PhamExecutive OfficerPonte Vedra, FL
Robert W LisickiDirectorPonte Vedra, FL
Glynn WilsonRelated PersonPonte Vedra, FL
STEVEN ZELENKOFSKERelated PersonPonte Vedra, FL
JAMES FERGUSONRelated PersonPonte Vedra, FL

Other filings by this issuer (6)

FiledFormOfferingSold
2026-07-15D$8.8M$8.8M
2026-04-06D$7.9M$7.9M
2025-12-31D$4.4M$4.4M
2024-11-14D$9.4M$9.4M
2022-12-08D$1.0M$250K
2022-07-25D$2.0M$150K

More